Comparative Evaluation of Tacrolimus Versus Interferon Alpha-2b Eye Drops in the Treatment of Vernal Keratoconjunctivitis: A Randomized, Double-Masked Study Reply

被引：0
|
作者：
Pourazizi, Mohsen [1 ]
Ghafourian, Abdolhossein [2 ]
机构：
[1] Isfahan Univ Med Sci, Dept Ophthalmol, Esfahan, Iran
[2] Univ Tehran Med Sci, Farabi Eye Hosp, Eye Res Ctr, Dept Ophthalmol, Tehran, Iran
来源：
CORNEA | 2018年 / 37卷 / 01期
关键词：
D O I：
10.1097/ICO.0000000000001371
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：E1 / E2
页数：4
相关论文
共 50 条
  • [21] Comment on: "Interferon Alpha-2b Eye Drops Prevent Recurrence of Pterygium After the Bare Sclera Technique: A Single-Center, Sequential, and Controlled Study"
    Gupta, Barkha
    Sahay, Pranita
    Kumawat, Devesh
    CORNEA, 2020, 39 (04) : E13 - E14
  • [22] 3-MILLION VERSUS 5-MILLION UNITS INTERFERON RECOMBINANT ALPHA-2B IN THE TREATMENT OF CHRONIC HEPATITIS-C - A RANDOMIZED STUDY
    AREIAS, J
    PEDROTO, I
    FREITAS, T
    CERQUEIRA, R
    TEIXEIRA, R
    PINHO, L
    JUSTICA, B
    SARAIVA, AM
    HEPATOLOGY, 1995, 22 (04) : 35 - 35
  • [23] Double-blind, multicenter, placebo-controlled trial of interferon alpha-2B plus ribavirin versus interferon alpha-2B for retreatment of relapsers and non-responders with chronic hepatitis C who failed previous treatment with interferon.
    Dettmer, R
    Reinus, J
    Clain, DJ
    Aytaman, A
    Levendoglu, H
    Bloom, AA
    Sarabanchong, V
    Puppo, MD
    Meyer, D
    Spinnell, M
    Garcia-Carrasquillo, RJ
    Magun, AM
    GASTROENTEROLOGY, 1999, 116 (04) : A1202 - A1202
  • [24] Efficacy and safety of tafluprost 0.0015% versus latanoprost 0.005% eye drops in open-angle glaucoma and ocular hypertension: 24-month results of a randomized, double-masked phase III study
    Uusitalo, Hannu
    Pillunat, Lutz E.
    Ropo, Auli
    ACTA OPHTHALMOLOGICA, 2010, 88 (01) : 12 - 19
  • [25] A phase 2 randomized, double-masked, placebo-controlled study of novel nonsystemic kinase inhibitor TOP1630 for the treatment of dry eye disease
    Taylor, Mike
    Ousler, George
    Torkildsen, Gail
    Walshe, Claire
    Fyfe, Matthew C. T.
    Rowley, Adele
    Webber, Steve
    Sheppard, John D.
    Duggal, Ajay
    CLINICAL OPHTHALMOLOGY, 2019, 13 : 261 - 275
  • [26] Topical interferon alpha 2b eye-drops for treatment of ocular surface squamous neoplasia: a dose comparison study
    Galor, A.
    Karp, C. L.
    Chhabra, S.
    Barnes, S.
    Alfonso, E. C.
    BRITISH JOURNAL OF OPHTHALMOLOGY, 2010, 94 (05) : 551 - 554
  • [27] INTERFERON ALPHA-2B TREATMENT OF CHRONIC POSTTRANSFUSION NON-A, NON-B HEPATITIS - INTERIM RESULTS OF A RANDOMIZED CONTROLLED OPEN STUDY
    WEILAND, O
    SCHVARCZ, R
    WEJSTAL, R
    NORKRANS, G
    FOBERG, U
    FRYDEN, A
    SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 1989, 21 (02) : 127 - 132
  • [28] A Phase 2 randomized, double-masked, placebo-controlled study of novel narrow spectrum kinase inhibitor TOP1630 for the treatment of dry eye syndrome
    Taylor, Mike
    Duggal, Ajay
    Walshe, Claire
    Fyfe, Matthew
    Rowley, Adele
    Webber, Steve
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [29] Evaluation of a standardized protocol of intracavitary recombinant interferon alpha-2b in the palliative treatment of malignant peritoneal effusions - A prospective pilot study
    Sartori, S
    Nielsen, I
    Tassinari, D
    Trevisani, L
    Abbasciano, V
    Malacarne, P
    ONCOLOGY, 2001, 61 (03) : 192 - 196
  • [30] Maintenance treatment with interferon alpha-2b in multiple myeloma:: a prospective randomized study from PETHEMA (Program for the Study and Treatment of Hematological Malignancies, Spanish Society of Hematology)
    Bladé, J
    San Miguel, JF
    Escudero, ML
    Fontanillas, M
    Besalduch, J
    Gardella, S
    Arias, J
    García-Conde, J
    Carnero, M
    Marti, JM
    Rozman, C
    Estapé, J
    Montserrat, E
    LEUKEMIA, 1998, 12 (07) : 1144 - 1148
12345